Toxic hepatitis after consumption of traditional kava preparation

Journal of Travel Medicine

Volumn 16, Issue 1, 2009, Pages 55-56

  Christl, Stefan U ^a   Seifert, Axel ^a   Seeler, Dirk ^a  

^a Asklepios Klinik Harburg   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; FERRITIN; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; KAVA; LACTATE DEHYDROGENASE;

ABDOMINAL SCINTISCANNING; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BEVERAGE; CASE REPORT; DIET SUPPLEMENTATION; DIETARY INTAKE; EYE JAUNDICE; FERRITIN BLOOD LEVEL; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE INFUSION; HISTOPATHOLOGY; HUMAN; JAUNDICE; LABORATORY TEST; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER TOXICITY; MALE; NUTRITIONAL ASSESSMENT; PHYSICAL EXAMINATION; PROTHROMBIN TIME; SAMOAN ISLANDS; TOXIC HEPATITIS;

ADULT; GLUCOSE; HEPATITIS, TOXIC; HUMANS; KAVA; LIVER FUNCTION TESTS; MALE; SAMOA; TREATMENT OUTCOME;

EID: 58449136396     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/j.1708-8305.2008.00259.x     Document Type: Article

References (12)

1. Pittler MH, Ernst E. Efficacy of kava extracts for treating anxiety: a systematic review and meta-analysis. J Clin Psychopharmacol 2000 20 : 84 89.
2. Kraft M, Spahn TW, Menzel J, et al. Fulminant liver failure after administration of the herbal antidepressant kava-kava. Dtsch Med Wochenschr 2001 126 : 970 972.
3. Strahl S, Ehret V, Dahm HH, Maier KP. Necrotizing hepatitis after taking herbal remedies. Dtsch Med Wochenschr 1998 123 : 1410 1414.
4. Stevinson C, Huntley A, Ernst E. A systematic review of the safety of kava extract in the treatment of anxiety. Drug Saf 2002 25 : 251 261.
5. Stickel F, Baumuller HM, Seitz K, et al. Hepatitis induced by kava (Piper methysticum rhizoma). J Hepatol 2003 39 : 62 67.
6. Teschke R. Kava, kavapyrones and toxic liver injury. Z Gastroenterol 2003 41 : 395 404.
7. Russmann S, Lauterburg PH, Helbling A. Kava hepatoxicity. Ann Intern Med 2001 135 : 68 69.
8. Clough AR, Bailie RS, Currie B. Liver function test abnormalities in users of aqueous kava extracts. J Toxicol Clin Toxicol 2003 41 : 821 829.
9. Clough AR, Jacups SP, Wang Z, et al. Health effects of kava use in an eastern Arnhem Land Aboriginal community. Intern Med J 2003 33 : 336 340.
10. Mathews JD, Riley MD, Fejo L, et al. Effects of the heavy usage of kava on physical health: summary of a pilot survey in an aboriginal community. Med J Aust 1988 148 : 548 555.
11. Russmann S, Barguil Y, Cabalion P, et al. Hepatic injury due to traditional aqueous extracts of kava root in New Caledonia. Eur J Gastroenterol Hepatol 2003 15 : 1033 1036.
12. Danan G, Benichou C. Causality assessment of adverse reactions to drugs - I. A novel method based on the conclusions of international consensus meetings: application to drug induced liver injuries. J Clin Epidemiol 1993 46 : 1323 1330.